Atherosclerosis （As） is a chronic inflammatory disease, and has relationship with self-immunity. Vulnerable plaque is crime culprit of most of acute cardiovascular events. Macrophage plays an essential role on plaque vulnerability of As. This paper focuses on how macrophage influences plaque vulnerability of As through “DAMP-PRR”pathway, and discusses new anti-As treatment therapy.